Recently, oncologist and researcher Paolo Tarantino, a Research Fellow at the Dana-Farber Cancer Ins...
Discussions Around Retraction of Debated Study on Early Morning Immunotherapy Benefits
Recently, oncologist and researcher Paolo Tarantino, a Research Fellow at the Dana-Farber Cancer Institute and Harvard Medical School, commented on the...
Author: Oncodaily
Read Original Article